Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryan Eldredge Wilcox
Observed names:
Ryan E. Wilcox,
Ryan Wilcox
Institution:
Intermountain Healthcare
Observed institutions:
Intermountain Healthcare,
Mayo Clinic
OpenAlex ID:
A5090867973
Efficacy of chemotherapy after treatment with regorafenib in metastatic colorectal cancer (mCRC).
2015
·
Michael Todd Kidd
, Ryan Eldredge Wilcox
, et al.
·
Journal of Clinical Oncology
·
11
Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2024
·
Vaibhav Sahai
, Michael Rothe
, et al.
·
JCO Precision Oncology
·
5
PDF
Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).
2015
·
Ryan Eldredge Wilcox
, Qian Shi
, et al.
·
Journal of Clinical Oncology
·
3
Evaluation of Multiple Myeloma Clinical Decision Support Tool Value When Populated with Community Health System Data
2020
·
Steven E. Labkoff
, Kathy E. Giusti
, et al.
·
Blood
·
1
Evaluation of multiple myeloma clinical decision support tool value for assessing treatment selection variation when populated with community health system data.
2021
·
Steven E. Labkoff
, Ryan Eldredge Wilcox
, et al.
·
Journal of Clinical Oncology
Using a tele-oncology service provides a direct benefit to patients and caregivers in rural communities in the Intermountain West.
2020
·
Derrick S. Haslem
, Zachary Reese
, et al.
·
Journal of Clinical Oncology
An update on high-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
2014
·
Ryan Eldredge Wilcox
, Mark Robert Litzow
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
7
Citation count:
20
H-index:
3
I10-index:
1
Year
Topic
Type